Carrier-free functionalized multidrug nanorods for synergistic cancer therapy

Biomaterials

Volumn 34, Issue 35, 2013, Pages 8960-8967

  Zhou, Mengjiao ^a   Zhang, Xiujuan ^a   Yang, Yinlong ^a   Liu, Zhuang ^a   Tian, Baishun ^a   Jie, Jiansheng ^a   Zhang, Xiaohong ^b  

^a SOOCHOW UNIVERSITY   (China)

^b TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY   (China)

Author keywords

10 Hydroxycamptothecin; Drug delivery; Methotrexate; Multidrug nanocrystals; Paclitaxel; Poly(ethylene glycol)methyl ethers

Indexed keywords

10 HYDROXYCAMPTOTHECIN (HCPT); COMBINATION CHEMOTHERAPY; IMAGING CAPABILITIES; INTRAVENOUS INJECTIONS; METHOTREXATE; METHYL ETHERS; PACLITAXEL; THERAPEUTIC EFFECTS;

CHEMOTHERAPY; DISEASES; DRUG DELIVERY; DRUG DOSAGE; NANOCRYSTALS; NANORODS; PHARMACODYNAMICS; POLYETHYLENE GLYCOLS;

LOADING;

10 HYDROXYCAMPTOTHECIN; MACROGOL; METHOTREXATE; NANOCRYSTAL; NANOROD; PACLITAXEL;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CELL STRAIN MCF 7; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG STABILITY; DRUG TOLERABILITY; HUMAN; HUMAN CELL; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL;

10-HYDROXYCAMPTOTHECIN; DRUG DELIVERY; METHOTREXATE; MULTIDRUG NANOCRYSTALS; PACLITAXEL; POLY(ETHYLENE GLYCOL)METHYL ETHERS;

ANIMALS; CAMPTOTHECIN; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HELA CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KB CELLS; MCF-7 CELLS; METHOTREXATE; MICE; MICE, INBRED BALB C; NANOPARTICLES; NANOTUBES; NEOPLASMS; PACLITAXEL;

EID: 84883255778     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.080     Document Type: Article

References (47)

1. Riehemann K., Schneider S.W., Luger T.A., Godin B., Ferrari M., Fuchs H. Nanomedicine-challenge and perspectives. Angew Chem Int Ed 2009, 48:872-897.
2. Li W., Yang Y.L., Wang C., Liu Z., Zhang X.J., An F.F., et al. Carrier-free, functionalized drug nanoparticles for targeted drug delivery. Chem Commun 2012, 48:8120-8122.
3. Min K.H., Park K., Kim Y.S., Bae S.M., Lee S., Jo H.G., et al. Hydrophobically modified glycol chitosan nanoparticles encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. JControl Release 2008, 127:208-218.
4. Kawano K., Watanabe M., Yamamoto T., Yokoyama M., Opanasopit P., Okano T., et al. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. JControl Release 2006, 112:329-332.
5. Xiao H.H., Song H.Q., Yang Q., Cai H.D., Qi R.G., Yan L.S., et al. Aprodrug strategy to deliver cisplatin (IV) and paclitaxel in nanomicelles to improve efficacy and tolerance. Biomaterials 2012, 33:6507-6519.
6. Lazikani B.A., Banerji U., Workman P. Combinatorial drug therapy for cancer in the post-genomic era. Nat Biotechnol 2012, 30:679-692.
7. Bahadur K.C.R., Xu P. Multicompartment intracellular self-expanding nanogel for targeted delivery of drug cocktail. Adv Mater 2012, 24:6479-6483.
8. Park K.S., Lee S.K., Kang E.N., Kim K.M., Choi K.W., Kwon I.C. New generation of multifunctional nanoparticles for cancer imaging and therapy. Adv Funct Mater 2009, 19:1553-1566.
9. Lee S.M., Park H.Y., Yoo K.H. Synergistic cancer therapeutic effects of locally delivered drug and heat using multifunctional nanoparticles. Adv Mater 2010, 22:4049-4053.
10. Chou T.C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010, 70:440-446.
11. Greco F., Vicent M.J. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev 2009, 61:1203-1213.
12. Mao L.N., Wang H.M., Tan M., Ou L.M., Kong D.L., Yang Z.M. Conjugation of two complementary anti-cancer drugs confers molecular hydrogels as a co-delivery system. Chem Commun 2012, 48:395-397.
13. Chen Y., Gao Y., Chen H.R., Zeng D.P., Li Y.P., Zheng Y.Y., et al. Engineering inorganic nanoemulsions/nanoliposomes by fluoride-silica chemistry for efficient delivery/co-delivery of hydrophobic agents. Adv Funct Mater 2012, 22:1586-1597.
14. Zhang J.X., Ma P.X. Polymeric core-shell assemblies mediated by host-guest interactions: versatile nanocarriers for drug delivery. Angew Chem Int Ed 2009, 48:964-968.
15. Aryal S., Hu C.M.J., Zhang L.F. Combinatorial drug conjugation enables nanoparticle dual-drug delivery. Small 2010, 6:1442-1448.
16. Yu D.S., Peng P., Dharap S.S., Wang Y., Mehlig M., Chandna P., et al. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth invivo. JControl Release 2005, 110:90-102.
17. Shen Y.Q., Jin E.L., Zhang B., Murphy C.J., Sui M.H., Zhao J., et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. JAm Chem Soc 2010, 132:4259-4265.
18. Tong R., Cheng J.J. Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles. Angew Chem Int Ed 2008, 120:4908-4912.
19. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A.H., Seaton A., et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008, 3:423-428.
20. Wu C.F., Chiu D.T. Highly fluorescent semiconducting polymer dots for biology and medicine. Angew Chem Int Ed 2013, 52:3086-3109.
21. Yang Y.L., An F.F., Liu Z., Zhang X.J., Zhou M.J., Li W., et al. Ultrabright and ultrastable near-infrared dye nanoparticles for invitro and invivo bioimaging. Biomaterials 2012, 33:7803-7809.
22. Wu W.T., Shen J., Banerjee P., Zhou S.Q. Multifunctional nanoplatform based on responsive fluorescent plasmonic ZnO-Au@PEG hybrid nanogels. Adv Funct Mater 2011, 21:2830-2839.
23. Wang C., Cheng L., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011, 32:1110-1120.
24. Diao X.J., Li W., Yu J., Wang X.J., Zhang X.J., Yang Y.Y., et al. Carrier-free, water dispersible and highly luminescent dye nanoparticles for targeted cell imaging. Nanoscale 2012, 4:5373-5377.
25. Kim D., Chae M.K., Joo H.J., Jeong I., Cho J.H., Lee C. Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for invivo applications. Langmuir 2012, 28:9634-9639.
26. Wickstrom M., Dyberg C., Shimokawa T., Milosevic J., Baryawno N., Fuskevag O.M., et al. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth invitro and invivo. Int J Cancer 2013, 132:1516-1524.
27. Liu S.H., Guo Y.B., Huang R.Q., Li J.F., Huang S.X., Kuang Y.Y., et al. Gene and doxorubicin co-delivery system for targeting therapy of glioma. Biomaterials 2012, 33:4907-4916.
28. Sun X.Q., Su J., Bao J.G., Peng T., Zhang L., Zhang Y.Y., et al. Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway. Biomaterials 2012, 33:8265-8276.
29. Arisaka Y., Kobayashi J., Yamato M., Akiyama Y., Okano T. Switching of cell growth/detachment on heparin-functionalized thermoresponsive surface for rapid cell sheet fabrication and manipulation. Biomaterials 2013, 34:4214-4222.
30. Geng Y., Dalhimer P., Cai S., Tsai R., Tewari M., Minko T., et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2007, 2:249-255.
31. Prakash S., Malhotra M., Shao W., Duchesneau C.T., Abbasi S. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Adv Drug Deliv Rev 2011, 63:1340-1351.
32. Pelegrin P., Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates. EMBO J 2009, 28:2114-2127.
33. Zhang Y.F., Yin Q., Yin L.C., Ma L., Tang L., Cheng J.J. Chain-shattering polymeric therapeutics with on-demand drug-release capability. Angew Chem Int Ed 2013, 52:6435-6439.
34. Hong M.H., Zhu S.J., Jiang Y.Y., Tang G.T., Pei Y.Y. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferring. JControl Release 2009, 133:96-102.
35. Miller K., Clementi C., Polyak D., Boock A.E., Benayoun L., Barshack L., et al. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases. Biomaterials 2013, 34:3795-3806.
36. Wong H.L., Chattopadhyay N., Wu X.Y., Bendayan R. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain. Adv Drug Deliv Rev 2010, 62:503-517.
37. Meng H., Liong M., Xia T., Li Z.X., Ji Z.X., Zink J.I., et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and p-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 2010, 4:4539-4550.
38. Li R.B., Wu R.A., Zhao L., Wu M.H., Yang L., Zou H.F. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells. ACS Nano 2010, 4:1399-1408.
39. Patil Y.B., Swaminathan S.K., Sadhukha T., Ma L.N., Panyamb J. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials 2010, 31:358-365.
40. Sun T.M., Du J.Z., Yao Y.D., Mao C.Q., Dou S., Huang S.Y., et al. Simultaneous delivery of siRNA and via a "two-in-one" micelleplex promotes synergistic tumor suppression. ACS Nano 2011, 5:1483-1494.
41. Wang F.H., Zhang D.R., Zhang Q., Chen Y.X., Zheng D.D., Hao L.L., et al. Synergistic effect of folate-mediated targeting and verapamil-mediated p-gp inhibition with paclitaxel polymer micelles to overcome multi-drug resistance. Biomaterials 2011, 32:9444-9456.
42. Yuan J.Y., Zhai Z.C., Dong H.L., Li J., Jiang Z.Q., Li Y.Y., et al. Efficient polymer solar cells with a high open circuit voltage of 1 volt. Adv Funct Mater 2013, 23:885-892.
43. Dutta P., Yang W., Eom S.H., Lee W.H., Kang I.N., Lee S.H. Development of naphtho[1,2-b:5,6-b']dithiophene based novel small molecules for efficient bulk-heterojunction organic solar cells. Chem Commun 2012, 48:573-575.
44. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2011, 7:653-664.
45. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009, 61:428-437.
46. Mullertza A., Ogbonnaa A., Rena S., Rades T. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. JPharm Pharmacol 2010, 62:1622-1636.
47. Boisselier E., Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009, 38:1759-1782.